Neocis, the leader in robotic dental implant technology, announced that clinicians have completed over 100,000 osteotomies using its Yomi® platform, highlighting growing adoption of robotics in implant dentistry.
The company also confirmed the first clinical procedures using Yomi S, its second-generation system, were successfully performed by Dr. Jay Neugarten, DDS, MD, FACS. These initial cases mark the transition of the new platform from development to clinical use, building on the proven foundation of more than 100,000 Yomi-guided osteotomies.
The milestone demonstrates Yomi’s consistent performance across various implant procedures and practice settings, emphasizing its role in enhancing precision and confidence during surgery.
“Reaching 100,000 osteotomies is more than a statistic — it shows that clinicians nationwide are integrating robotics into daily surgical workflows,” said Alon Mozes, CEO and co-founder of Neocis. “This usage reflects trust in the technology and confirms that robotics is setting a new standard of care.”
Yomi is the first and only FDA-cleared robotic system for dental implant surgery. Introduced in 2025, Yomi S combines real-time haptic guidance, pre-operative digital planning, and intra-operative adaptability to assist clinicians in a variety of cases, from single-tooth implants to full-arch procedures.
“Clinicians increasingly seek technologies that integrate smoothly with existing workflows while delivering tangible value,” said Dennis Moses, CTO of Neocis. “The 100,000-osteotomy milestone validates Yomi’s robustness and its consistent performance in real-world settings.”
Neocis continues to enhance Yomi through software upgrades, workflow optimization, and advanced planning tools, aiming to expand clinical applications and improve procedural efficiency.
The milestone reinforces Neocis’ commitment to advancing robotic innovation in dentistry and supporting clinicians in delivering high-quality implant care.